aspsirna0564 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0564
siRNA Name: AlphaS226F-M9-shRNA
Gene:Cholinergic receptor, nicotinic, alpha 1 (CHRNA1)(muscle)
Disease:Congenital myasthenic syndrome (SCCMS)
Wild allele/target (5'->3'): GCUCUUCUCCUUCUUAACU
Mutant allele/target (5'->3'):GCUCUUCUUCUUCUUAACU
Target Mutation: c.737C>T,p.Ser271Phe
Wild siRNA (As strand):CGAGAAGAGGAAGAAUUGA
ASP-siRNA (As strand):CGAGAAGAAGAAGAAUUGA
Mismatch position in siRNA: A11G
Mutant allele (5'->3'): GCUCUUCUUCUUCUUAACU
ASP-siRNA (As strand):CGAGAAGAAGAAGAAUUGA
ASP-siRNA efficacy for mutant allele:Low efficacy
Wild allele (5'->3'): GCUCUUCUCCUUCUUAACU
ASP-siRNA (As strand):CGAGAAGAAGAAGAAUUGA
ASP-siRNA efficacy for wild allele:High efficacy
Percentage discrimination for ASP-siRNA:High discrimination
Wild allele (5'->3'): GCUCUUCUCCUUCUUAACU
Wild siRNA (As strand):CGAGAAGAGGAAGAAUUGA
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): GCUCUUCUCCUUCUUAACU
ASP-siRNA (As strand):CGAGAAGAAGAAGAAUUGA
Wild sirna efficacy for mutant allele:4
Percentage discrimination for wild siRNA:NA
Concentration:100pmol
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P02708
Target sequence: TCCCCTGCCTGCTCTTCTCCTTCTTAACTGGCCTGGT
Genbank Accesion: NM_001039523.2
Cell-line: HEK293
Experimental technique used: 125 I-a-bungarotoxin binding aSay
Transfection method: Polyethyleneimine
siRNA expression method: Dharmacon
Post-transfection duration: 48 hours
OMID ID: 608931
KEGG disease ID:H00770
Reference:12928480

.
.
.
.
.
.
.
.
.
.
.

.

.

.